D&D PHARMATECH
D&D Pharmatech is a operator of a holding company created to fund the development of therapeutic medicines through disease-specific subsidiary companies founded and guided by top-tier medical research faculty. The company's product pipeline focuses on a range of indications including neurodegenerative, metabolic and fibrotic diseases, providing the opportunity to accelerate the translation of cutting-edge research into lifesaving therapeutic products for patients.
D&D PHARMATECH
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2014-01-01
Status:
Active
Total Funding:
224.1 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Apache Mobile Non Scaleable Content Google Apps For Business Google Maps Google Maps API Sectigo SSL
Similar Organizations
FAB Pharmaceuticals
FAB Pharmaceuticals is a Health Care Company.
Frontier Biotechnologies
Frontier Biotechnologies is a commercial-stage bio-pharmaceutical company.
Pearl Care
Pearl Care is Healthcare company.
Pharmate
Pharmate is a health care company.
StanPlus
A Health And Healthcare Company.
Trinomab
Trinomab is a Healthcare company.
Current Employees Featured
Founder
Investors List
DS Asset Management
DS Asset Management investment in Series C - D&D Pharmatech
Praxis Capital Partners
Praxis Capital Partners investment in Series C - D&D Pharmatech
Korea Investment Securities
Korea Investment Securities investment in Series C - D&D Pharmatech
Kudos Venture Capital
Kudos Venture Capital investment in Series C - D&D Pharmatech
Magna Investment
Magna Investment investment in Series B - D&D Pharmatech
InterVest Co.
InterVest Co. investment in Series B - D&D Pharmatech
Octave Life Sciences
Octave Life Sciences investment in Series B - D&D Pharmatech
LB Investment
LB Investment investment in Series B - D&D Pharmatech
Smilegate Investment
Smilegate Investment investment in Series B - D&D Pharmatech
LB Investment
LB Investment investment in Series A - D&D Pharmatech
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2018-07-18 | Neuraly | D&D Pharmatech investment in Series A - Neuraly | 36 M USD |